Greece's Pharma industry faced with most challenging environment in Europe

It is now beyond doubt that drugmakers in Greece - particularly domestic producers, primarily exposed to their home market - are faced with the most challenging operating environment in Europe, according to a new report from Business Monitor International. BMI's view that the Greek pharmaceutical market is set for a decade of decline remains firmly in play.

The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic drug substitution; out-of-control hospital debt; extensive payment delays; drug shortages; and the prospect of a “money saving” positive reimbursement list are a few of the obstacles faced by those operating in the market, says BMI.